Celltheon - About the company
Celltheon is a funded company based in Union City (United States), founded in 2012 by Amita Goel. It operates as a Biologics innovator providing custom cell line and manufacturing solutions. Celltheon has raised an undisclosed amount in funding. The company has 1950 active competitors, including 452 funded and 337 that have exited. Its top competitors include companies like Sutro Biopharma, Synthego and Avidity Biosciences.
Company Details
Biologics innovator providing custom cell line and manufacturing solutions. The company specializes in custom cell line development and manufacturing solutions for complex biologics, offering services from early drug development to manufacturing. They leverage protein expression technologies to provide solutions for products at all phases of development, including centralized production, purification, and analytical services. Services include cell line development, process development, analytical characterization, and bioproduction. The company offers a platform for protein formats, enabling rapid production, purification, and characterization of protein variants. They develop analytical methods to characterize protein attributes and offer cell-based assay development services. The company's platform enables production of material for tox studies, downstream process development, and upstream process development. They focus on seamless tech transfer of manufacturing processes.
- Website
- celltheon.com
- Email ID
- *****@celltheon.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2012
Location
Union City, United States
Stage
Funding Raised
Latest Funding Round
Ranked
730th among 1950 active competitors
Employee Count
17 as on May 31, 2026
Similar Companies
Sign up to download Celltheon's company profile
Celltheon's funding and investors
Celltheon has raised funding over 1 round.
Here is the list of recent funding rounds of Celltheon:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 24, 2019 | 4903075 | Conventional Debt | 4528346 | 8422971 | 4930921 | 6434094 |
Access funding benchmarks and valuations. Sign up today!View details of Celltheon's funding rounds and investors
Celltheon's founders and board of directors
Founder? Claim ProfileThe founders of Celltheon is Amita Goel. Amita Goel is the CEO of Celltheon.
Here are the details of Celltheon's key team members:
- Amita Goel: Founder/ CEO of Celltheon. Contact Info: 1 email address
View details of Celltheon's Founder profiles and Board Members
Celltheon's employee count trend
Celltheon has 17 employees as of May 26. Here is Celltheon's employee count trend over the years:
Uncover Celltheon's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Celltheon's Competitors and alternates
Top competitors of Celltheon include Sutro Biopharma, Synthego and Avidity Biosciences. Here is the list of Top 10 competitors of Celltheon, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
2nd | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
3rd |  Avidity Biosciences 2012, San Diego (United States), Acquired | RNA therapeutics innovator targeting muscle and other diseases with AOC platform | $143M | 70/100 | |
4th | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
5th | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
6th | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
7th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
8th | Life Biosciences 2017, Boston (United States), Series D | Biotechnology pioneering cellular rejuvenation therapies to reverse and prevent aging diseases | $261M | 64/100 | |
9th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
10th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
730th | Celltheon 2012, Union City (United States), Funding Raised | Biologics innovator providing custom cell line and manufacturing solutions | - | - | 30/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Celltheon's competitors? Click here to see the top ones
Celltheon's Investments and acquisitions
Celltheon has made no investments or acquisitions yet.
News related to Celltheon
•
•
Celltheon Launches Revolutionary OmniCHO™ Transient Expression KitBusiness Wire•Oct 23, 2024•Celltheon
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Celltheon
Explore our recently published companies
- Wicked Wizard - United States based, 2004 founded, Unfunded company
- Oliveira - United Kingdom based, Unfunded company
- Zeus - Manchester based, 2016 founded, Unfunded company
- Hotel Blue Horizon - Kathmandu based, 1992 founded, Unfunded company
- DeWorld - Singapore based, 2023 founded, Unfunded company
- Crowlandcarpets - United Kingdom based, Unfunded company
